Viral vectors for malaria vaccine development.

Viral vectors for malaria vaccine development.

A workshop on viral vectors for malaria vaccine development, organized by the PATH Malaria Vaccine Initiative, was held in Bethesda, MD on October 20, 2005. Recent advancements in viral-vectored malaria vaccine development and emerging vector technologies were presented and discussed. Classic viral...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Li, S, Locke, E, Bruder, J, Clarke, D, Doolan, D, Havenga, M, Hill, A, Liljestrom, P, Monath, T, Naim, H, Ockenhouse, C, Tang, D, Van Kampen, K, Viret, J, Zavala, F, Dubovsky, F
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2007

Παρόμοια τεκμήρια

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
ανά: Milicic, A, κ.ά.
Έκδοση: (2017)

Viral vector vaccines
ανά: McCann, N, κ.ά.
Έκδοση: (2022)

Viral vector vaccines make memory T cells against malaria.
ανά: Reyes-Sandoval, A, κ.ά.
Έκδοση: (2007)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
ανά: Forbes, E
Έκδοση: (2011)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
ανά: Kapulu, MC
Έκδοση: (2014)

Viral vectors as vaccine platforms: Deployment in sight
ανά: Rollier, C, κ.ά.
Έκδοση: (2011)

Viral vectors as vaccine platforms: deployment in sight.
ανά: Rollier, C, κ.ά.
Έκδοση: (2011)

Effective induction of high-titer antibodies by viral vector vaccines.
ανά: Draper, S, κ.ά.
Έκδοση: (2008)

Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
ανά: Ewer, K, κ.ά.
Έκδοση: (2015)

Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches
ανά: Pearson, FE
Έκδοση: (2011)

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection
ανά: Elias, S, κ.ά.
Έκδοση: (2014)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
ανά: Venkatraman, N, κ.ά.
Έκδοση: (2017)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
ανά: Bliss, C, κ.ά.
Έκδοση: (2018)

Viral vectors as vaccine platforms: from immunogenicity to impact
ανά: Ewer (nee Russell), K, κ.ά.
Έκδοση: (2016)

New vectored vaccines for malaria.
ανά: Hill, A, κ.ά.
Έκδοση: (2008)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
ανά: Forbes, E, κ.ά.
Έκδοση: (2011)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
ανά: Kapulu, M, κ.ά.
Έκδοση: (2010)

Clinical advances in viral-vectored influenza vaccines
ανά: Sebastian, S, κ.ά.
Έκδοση: (2018)

Novel viral vector vaccines for tropical infections
ανά: Rampling, T
Έκδοση: (2017)

Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
ανά: Elias, S, κ.ά.
Έκδοση: (2013)

Comparing human T cell and NK cell responses in viral-based malaria vaccine trials.
ανά: Berthoud, T, κ.ά.
Έκδοση: (2009)

Clinical development of viral vectored vaccines against MERS-COV
ανά: Ewer, K, κ.ά.
Έκδοση: (2018)

Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants
ανά: Bliss, C, κ.ά.
Έκδοση: (2016)

Developing viral vectored vaccines for MAGE-expressing tumours
ανά: McAuliffe, J
Έκδοση: (2020)

Baculovirus expression vector system for production of viral vaccines /
ανά: 300419 Vlak, J. M., κ.ά.

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
ανά: Nébié, I, κ.ά.
Έκδοση: (2014)

Prime-boost vectored malaria vaccines: progress and prospects.
ανά: Hill, A, κ.ά.
Έκδοση: (2010)

Biodegradable pulsatile release technologies for viral vector based vaccinations
ανά: Krastev, C
Έκδοση: (2018)

Adeno‐associated viral vectored delivery of a monoclonal antibody gene against blood‐stage malaria
ανά: Bardelli, M, κ.ά.
Έκδοση: (2019)

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
ανά: Silk, SE, κ.ά.
Έκδοση: (2023)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
ανά: Vuola, J, κ.ά.
Έκδοση: (2005)

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria
ανά: Ewer (nee Russell), K, κ.ά.
Έκδοση: (2018)

Developing combination therapy to improve viral vector cancer vaccine efficacy
ανά: Noblecourt, L
Έκδοση: (2023)

T and B cell responses to multivalent prime-boost DNA and viral vectors vaccine combinations against Hepatitis C virus in non-human primates
ανά: Rollier, C, κ.ά.
Έκδοση: (2016)

Acquired immunity to malaria.
ανά: Doolan, D, κ.ά.
Έκδοση: (2009)

Progress with new malaria vaccines.
ανά: Webster, D, κ.ά.
Έκδοση: (2003)

Malaria vaccines.
ανά: Moorthy, V, κ.ά.
Έκδοση: (2002)

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
ανά: Hodgson, S, κ.ά.
Έκδοση: (2014)

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus
ανά: López-Camacho, C, κ.ά.
Έκδοση: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
ανά: Antrobus, R
Έκδοση: (2014)